0009K0 — Aimed Bio Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩4tn
- KR₩3tn
- KR₩47bn
Annual cashflow statement for Aimed Bio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -9,030 | -3,313 | 5,018 |
| Depreciation | |||
| Amortisation | |||
| Non-Cash Items | 3,698 | 3,704 | 16,801 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 1,629 | -6,728 | -5,341 |
| Change in Accounts Receivable | |||
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -2,644 | -4,874 | 17,860 |
| Capital Expenditures | -796 | -1,680 | -363 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | -13,704 | -14,709 | -33,572 |
| Sale of Fixed Assets | |||
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -14,500 | -16,389 | -33,935 |
| Financing Cash Flow Items | 76.8 | — | — |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 15,734 | 24,270 | 118,462 |
| Foreign Exchange Effects | |||
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -1,410 | 3,026 | 101,920 |